Published in Chin Med J (Engl) on April 01, 1983
Kaposi's sarcoma in HIV-negative homosexual men. Lancet (1990) 2.80
Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody. Proc Natl Acad Sci U S A (1991) 2.71
Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol (2001) 2.32
New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer (1999) 2.05
Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer (2001) 1.94
Acyl coenzyme a preference of the glycerol phosphate pathway in the microsomes from the maturing seeds of palm, maize, and rapeseed. Plant Physiol (1988) 1.91
Association study of neuregulin 1 gene with schizophrenia. Mol Psychiatry (2003) 1.89
Surgery of small hepatocellular carcinoma. Analysis of 144 cases. Cancer (1989) 1.82
Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer (1996) 1.78
The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer (1992) 1.68
A primary intestinal helminthic infection rapidly induces a gut-associated elevation of Th2-associated cytokines and IL-3. J Immunol (1993) 1.62
Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol (2001) 1.55
Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer (1993) 1.33
High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential. Hepatology (2000) 1.32
The beta actin promoter. High levels of transcription depend upon a CCAAT binding factor. J Biol Chem (1989) 1.29
The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res (1999) 1.25
Calonectria species associated with cutting rot of Eucalyptus. Persoonia (2010) 1.24
Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice. J Natl Cancer Inst (2000) 1.23
Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome. Clin Diagn Lab Immunol (1999) 1.23
Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Virology (1997) 1.22
Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein. World J Gastroenterol (2001) 1.21
Microvessel density of hepatocellular carcinoma: its relationship with prognosis. J Cancer Res Clin Oncol (1999) 1.21
Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA. Proc Natl Acad Sci U S A (1989) 1.19
Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma. J Exp Clin Cancer Res (1998) 1.18
Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver (1994) 1.17
A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33. Eur J Biochem (2001) 1.16
Progress and prospects in hepatocellular carcinoma surgery. Ann Chir (1998) 1.15
Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis. World J Gastroenterol (2001) 1.15
Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma. Dig Surg (1998) 1.14
Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol (1993) 1.14
Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor. J Cancer Res Clin Oncol (2000) 1.13
Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. J Hepatol (1996) 1.13
Telomere erosion is independent of microsatellite instability but related to loss of heterozygosity in gastric cancer. World J Gastroenterol (2001) 1.09
Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Report of 60 cases. Cancer (1988) 1.09
Surgical treatment of recurrent hepatocellular carcinoma. Hepatogastroenterology (1993) 1.08
Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential. World J Gastroenterol (2001) 1.08
Detection of HIV antigen and specific antibodies to HIV core and envelope proteins in sera of patients with HIV infection. Blood (1987) 1.07
Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion. J Clin Immunol (1999) 1.07
Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1. J Cancer Res Clin Oncol (1999) 1.07
Complete resection of the caudate lobe of the liver with tumor: technique and experience. Hepatogastroenterology (2001) 1.06
Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus. J Cancer Res Clin Oncol (2000) 1.06
Replication of hepatitis B virus in a hepatocellular carcinoma. Virology (1990) 1.03
Serum alanine aminotransferase level in relation to hepatitis B and C virus infections among blood donors. Liver (1997) 1.03
Identification of two nuclear factor-binding domains on the chicken cardiac actin promoter: implications for regulation of the gene. Mol Cell Biol (1989) 1.03
Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. Br J Cancer (1997) 1.02
Role of histamine H(1) receptor in pain perception: a study of the receptor gene knockout mice. Eur J Pharmacol (2000) 1.01
Shaping ability of progressive versus constant taper instruments in simulated root canals. Int Endod J (2006) 1.01
Duplex pulsed Doppler sonography of portal vein thrombosis in hepatocellular carcinoma. J Ultrasound Med (1991) 1.01
Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C. Eur J Endocrinol (2000) 1.00
Novel species of Calonectria associated with Eucalyptus leaf blight in Southeast China. Persoonia (2011) 1.00
Cryotherapy for primary liver cancer. Semin Surg Oncol (1998) 1.00
Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan. J Med Virol (2001) 0.99
Artifact-resistant power-efficient design of finger-ring plethysmographic sensors. IEEE Trans Biomed Eng (2001) 0.99
The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta (1994) 0.99
Multiresidue gas chromatographic method for determining synthetic pyrethroid pesticides in agricultural products: collaborative study. J AOAC Int (1999) 0.99
Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. Br J Cancer (1994) 0.99
Shaping ability of progressive versus constant taper instruments in curved root canals of extracted teeth. Int Endod J (2007) 0.98
Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study. Br J Cancer (2001) 0.97
Abnormal beta-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China. World J Gastroenterol (2001) 0.97
Factors influencing primary liver cancer resection survival rate. Chin Med J (Engl) (1981) 0.97
Recurrence after resection of alpha-fetoprotein-positive hepatocellular carcinoma. J Cancer Res Clin Oncol (1994) 0.96
Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B. Scand J Gastroenterol (1994) 0.96
Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test. J Clin Microbiol (2000) 0.95
CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J Immunol (1997) 0.94
Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection. World J Gastroenterol (2001) 0.94
Mouse running activity is lowered by Brucella abortus treatment: a potential model to study chronic fatigue. Physiol Behav (1998) 0.94
Frequency, species and molecular characterization of oral Candida in hosts of different age in China. J Oral Pathol Med (2005) 0.94
Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol (1991) 0.94
Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevations during a primary systemic in vivo immune response. J Immunol (1995) 0.93
Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J Med Virol (1994) 0.93
Hepatocellular carcinoma: some aspects to improve long-term survival. J Surg Oncol (1989) 0.93
Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-κB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells. Mol Cell Biochem (2011) 0.93